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Effects of bioplus 2B and Levucell SB on weanling pig growth performance and
fecal shedding in response to oral challenge with salmonella serovar
typhimurium
Abstract
Eighty-five pigs (initially 12.9 lb and 15 Â±1 d of age) were used in two 28-d trials to determine the effects
of the probiotics BioPlus 2B (a bacillus-based product from Chr. Hansen BioSystems), a source of
Bacillus subtilis and Bacillus licheniformis, and Levucell SB (an active dry yeast product from Lallemand
Animal Nutrition), a yeast (Saccharomyces cerevisiae) product that is a source of
mannanoligosaccharides on growth and performance of Salmonella enterica serovar Typhimurium
shedding in a young growing pig model. Pigs were fed one of five dietary treatments: 1) A control diet
containing no probiotics or antibiotics; 2) the control diet with carbadox (50 g/ton); 3) the control diet with
Bio-Plus 2B (0.05% of the diet); 4) the control diet with Levucell SB (100 g/ton); 5) the control diet with
Bioplus 2B (0.05% of the diet) and Levucell SB (100 g/ton). Diets did not contain growth promoting levels
of zinc oxide or copper sulfate. Significant differences in the two trials were seen, with the second trial
having 0.1 lb/d greater growth and .18 lb/d greater feed intake than the first trial. In trial 1, pigs fed the
control diet and Bioplus 2B had greater gains and feed intakes (P<0.05 and P<0.02 respectively) than
those fed carbadox. In trial two, pigs fed carbadox had better performance than those fed the control and
combination diets, with the BioPlus 2B and Levucell SB treatments having intermediate growth and feed
intake. Fecal shedding rates of salmonella were not different (P>0.10) between diets. Results indicate
that within an environment where enteric disease may be active, BioPlus 2B and Levucell SB may provide
growth enhancement over a diet devoid of antimicrobials.; Swine Day, 2003, Kansas State University,
Manhattan, KS, 2003
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EFFECTS OF BIOPLUS 2B AND LEVUCELL SB ON WEANLING PIG GROWTH
PERFORMANCE AND FECAL SHEDDING IN RESPONSE TO ORAL CHALLENGE
WITH SALMONELLA SEROVAR TYPHIMURIUM
M.R. Barker, S.S. Dritz1, J.C. Nietfeld2, and J.E. Minton

gains and feed intakes (P<0.05 and P<0.02
respectively) than those fed carbadox. In trial
two, pigs fed carbadox had better performance
than those fed the control and combination
diets, with the BioPlus 2B and Levucell SB
treatments having intermediate growth and
feed intake. Fecal shedding rates of salmonella were not different (P>0.10) between diets. Results indicate that within an environment where enteric disease may be active,
BioPlus 2B and Levucell SB may provide
growth enhancement over a diet devoid of antimicrobials.

Summary
Eighty-five pigs (initially 12.9 lb and 15
±1 d of age) were used in two 28-d trials to
determine the effects of the probiotics BioPlus
2B (a bacillus-based product from Chr. Hansen BioSystems), a source of Bacillus subtilis
and Bacillus licheniformis, and Levucell SB
(an active dry yeast product from Lallemand
Animal Nutrition), a yeast (Saccharomyces
cerevisiae) product that is a source of mannanoligosaccharides on growth and performance of Salmonella enterica serovar Typhimurium shedding in a young growing pig
model.

(Key Words: Weanling Pigs, Disease Challenge, Salmonella, BioPlus 2B, and Saccharomyces cerevisiae)

Pigs were fed one of five dietary treatments: 1) A control diet containing no probiotics or antibiotics; 2) the control diet with carbadox (50 g/ton); 3) the control diet with BioPlus 2B (0.05% of the diet); 4) the control diet
with Levucell SB (100 g/ton); 5) the control
diet with Bioplus 2B (0.05% of the diet) and
Levucell SB (100 g/ton). Diets did not contain growth promoting levels of zinc oxide or
copper sulfate.

Introduction
With greater consumer concerns over antibiotic resistance, there has been increased
pressure to remove and find alternatives to
antibiotics in livestock diets Alternatives to
antimicrobials that may hold promise include
probiotic feed additives. Supplementation of
swine diets with probiotics to alter the intestinal microbial population and to promote gut
health has shown variable responses in
growth. Possible reasons for variation among
trials may be due to various levels and species
of enteric organisms within production sys-

Significant differences in the two trials
were seen, with the second trial having 0.1
lb/d greater growth and .18 lb/d greater feed
intake than the first trial. In trial 1, pigs fed
the control diet and Bioplus 2B had greater
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lected on d 21 and 28 days to be cultured for
semi-quantitative counts of salmonellae.

tems. Weanling pigs were fed the probiotics
Bioplus 2B, a bacillus-based product, and Levucell SB, an active yeast culture, in order to
determine the growth responses and bacterial
shedding rates in the presence of an orally
administered enteric pathogenic challenge.

Table 1. Diet Compositionab (As-fed)
Ingredients
Corn
Soybean meal
Spray dried whey
Select menhaden fishmeal
Soy oil
Monocalcium phosphate, 21% P
Limestone
Salt
Vitamin premix
Trace mineral premix
Lysine HCl
DL-Methionine
Cornstarchb
Total

Materials and Methods
The Kansas State University Institutional
Animal Care and Use Committee approved
the experimental protocol used in this study.
Eighty-five weanling pigs (initially 12.9 lb)
were blocked by initial weight and allotted to
one of five dietary treatments in two 28 d trials. Two pigs were assigned to a pen, with a
total of eight or nine replicates per treatment.
All pigs were housed in two environmentally
controlled rooms. One feeder and one nipplewaterer were provided in each pen to allow ad
libitum access to feed and water. All pigs
were fed a common diet for the first 7 d after
weaning. The pigs were switched to the experimental dietary treatments for 14 d before
inoculation. The basal diet contained no
added antimicrobials, while the positive control diet contained carbadox (50 g/ton). The
three test diets contained a bacillus-based
product (BioPlus 2B, Chr. Hansen BioSystems; 0.05% of the diet), an active dry yeast
product (Levucell SB, Lallemand Animal Nutrition; 100 g/ton), and a combination of the
two products. The experimental diets were fed
in meal form (Table 1).

Calculated analysis
Lysine, %
ME, kcal/kg
Calcium, %
Phosphorous, %

Control
50.74
27.94
10.00
4.50
3.00
1.20
0.68
0.35
0.25
0.15
0.15
0.05
1.00
100.00%

1.39%
3388
0.90
0.79

a

Diets did not contain growth promoting levels of zinc oxide or copper sulfate.
b
Test ingredients, carbadox (50 g/ton), BioPlus 2B (0.05% of the diet), and Levucell SB
(100 g/ton) replaced cornstarch to provide
the additional dietary treatment.
A semi-quantitative method for evaluating
Salmonella shedding was developed for the
experiment. Salmonella growth was classified
into one of four categories; 1) confluent
growth over the entire agar plate (score 3); 2)
any number of wells with growth on the agar
plate (score 2); 3) only growth that was obtained on enrichment (score 1); 4) or no
growth detected (score 0). The shedding and
colonization scores were analyzed using the
non-parametric Kruskal-Wallis Test. On d 27
and 28 of the study pigs were euthanized and
fecal samples from the colon were collected
and tested for the presence of culturable Salmonella.

Prior to challenge, fecal samples were
taken to insure that all animals were not shedding salmonellae organisms. On d 14, pigs
were inoculated with Salmonella enterica serovar Typhimurium (2.36 × 106 and 1.22 x 106
CFU in trials 1 and 2, respectively). This dose
was used to closely mimic a chronic, but containable gut pathogen load. Rectal temperatures and feed intakes were determined daily
for the first week after inoculation. Pigs were
weighed and ADFI, ADG, and F/G were determined on days 0, 7, 14, 21, and 28 of the
experimental period. Fecal samples were col137

propriate level and the negative control contained no antimicrobials. At present we don’t
have an explanation for the failure of carbadox
to improve growth performance compared
with control pigs. Pigs fed the Bioplus 2B
diets performed similarly to the pigs fed the
control diet, with the Levucell and combination fed pigs performing intermediate in response to enteric challenge. The combination
of the two probiotics showed no additive
benefit before or after enteric challenge.

Data were analyzed in a randomized complete block design replicated over time using
the Mixed model procedures of SAS. All
means presented are least-square means.
Results and Discussion
Both trials are reported separately due to
significant trial differences (P<0.05) for all
variables except feed efficiency, and diet x
trial interactions (P<0.05) for all variables except feed efficiency and daily rectal temperatures.

Trial 2. Pigs fed carbadox had greater
ADG (P<0.05) and ADFI (P<0.04) when
compared to the pigs fed the control, Bioplus
2B, and combination diets prior to challenge
(Figure 1, right panels). Pigs fed the diet containing Levucell had intermediate ADG
(P<0.07) and ADFI (P<0.04) in comparison to
carbadox and control, Bioplus 2B, or the combination diets. In the 2 weeks following bacterial challenge pigs fed the diet containing
carbadox had greater ADG than pigs fed the
control diet (P<0.01), with the Bioplus 2B,
Levucell, and combination fed pigs intermediate in growth (P<0.40). Following challenge,
carbadox-fed pigs had greater feed intakes
than the control or combination-fed pigs (P<
0.01). The Bioplus 2B and Levucell-fed pigs
were also higher (P<0.05) in feed intake than
the control. Overall, carbadox-fed pigs had
greater growth than the control (P<0.01) and
combination diets (P<0.05), with pigs fed
Bioplus 2B (P<0.09) and Levucell having intermediate performance (P<0.12). Overall in
trial 2, the carbadox fed pigs had greater
(P<0.02) feed intake than the control or combination pigs. The Bioplus 2B and Levucell
fed pigs were intermediate in intake. There
were no differences in feed efficiency.

Growth Performance
Trial 1. No differences in ADG or ADFI
were seen in the two weeks prior to challenge
(Figure 1, left panels). In the two weeks following challenge the pigs fed the control diet
or Bioplus 2B diet had greater ADG than pigs
fed the antibiotic or Levucell diets (P<0.01).
Pigs fed the diet containing the combination of
Bioplus 2B and Levucell had decreased ADG
compared to the control pigs (P>0.03), but not
with the pigs fed the diet containing Levucell
(P<0.06). Greater feed intakes were observed
for the pigs fed the control diet and diet containing Bioplus 2B compared to the pigs fed
carbadox, Levucell, or the combination treatment (P<0.03). For the overall trial, pigs fed
the control and Bioplus 2B diets had greater
ADG and ADFI than the pigs fed carbadox,
with the pigs fed Levucell and the combination being intermediate in ADG (P<0.03) and
ADFI (P<0.02). No differences were observed
in feed efficiency.
Growth performance in the first trial was
surprising in that pigs fed carbadox gained
more slowly than control pigs. No obvious
reasons for this effect could be identified. Initially it was hypothesized that the carbadox
and control diets may have been accidentally
switched at the feed mill. However, upon
analysis of the diets at a commercial laboratory, it was determined that the carbadox diet
did indeed contain the antimicrobial at the ap-

The increase in feed intake and growth
when feeding carbadox both before and after
enteric challenge is consistent with several
previous research trials in our laboratory.
Bioplus 2B and Levucell SB pigs were intermediate in growth and feed intake in comparison to the control and carbadox-treated pigs.
138

days 21 and 28 of the trials. No obvious
treatment differences were observed.

Although neither Levucell nor Bioplus 2B
treatments matched carbadox in growth response, both did numerically, though not significantly, better than the control fed pigs.
The combination of Bioplus 2B and Levucell
showed no additive benefit before or after
challenge.

Summary
Growth performance and feed intake were
not typical in trial 1 for the control and antibiotic treatments in comparison to previous research conducted within our laboratory. Reasons for the underperformance of the antimicrobial regimen are uncertain in the presence
of an enteric pathogen. However, trial 2
showed all treatments having improved performance over the control diet. Trial 2 also
showed the expected growth enhancement
properties of carbadox in the presence of enteric disease. Although not significant, Bioplus 2B and Levucell showed improvement
over the control with about a 10% improvement in growth and 7% improvement in feed
intake. The combination treatment showed
only a 7% improvement in growth over the
control in trial 2. These, diets containing Bioplus 2B or Levucell SB in a production environment may provide improved growth enhancement over diets with no antimicrobials
in the presence of an enteric pathogen.

Fecal Salmonella Shedding Scores
Fecal Salmonella were cultured and measured 7 and 14 d following challenge with Salmonella serotype Typhimurium (corresponds
to d 21 and 28 of trials). Pen shedding scores
did not differ between treatments and were
low and variable between days and trials, generally ranging between scores of 0 and 1
among treatments.
Initially it was hypothesized that fecal
scores would be lowest for carbadox treated
pigs, with the Bioplus 2B and Levucell being
intermediate. Our hypothesis was based on
the ability of antimicrobials to inhibit the
growth of pathogenic organisms within the
gut. Throughout both trials, fecal scores were
typically low for presence of Salmonella for
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Figure 1. Effect of BioPlus 2B and Levucell SB on growth performance of weaned pigs
prior to and after oral challenge with 106 Salmonella Serovar Typhimurium on d 14 in
both trials. The number of pens per treatment is given in parenthesis in the figure legends.
Within period bars with different superscripts differ (P< 0.05).
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